Predictors of mortality in multidrug-resistant Klebsiella pneumoniae bloodstream infections

References

• Hippocrates. Hippocrates Volume II: Prognostic. Jones WHS ( Ed.). Harvard University Press, Boston (1923).
   Google Scholar
• Braykov NP, Eber MR, Klein EY, Morgan DJ, Laxminarayan R. Trends in resistance to carbapenems and third-generation cephalosporins among clinical isolates of Klebsiella pneumoniae in the United States, 1999–2010. Infect. Control Hosp. Epidemiol. 34(3), 259–268 (2013).
   PubMed Web of Science ®Google Scholar
• Canton R, Akova M, Carmeli Y et al. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin. Microbiol. Infect. 18(5), 413–431 (2012).
   PubMed Web of Science ®Google Scholar
• Rodriguez-Bano J, Pascual A. Clinical significance of extended-spectrum beta-lactamases. Expert Rev. Anti. Infect. Ther. 6(5), 671–683 (2008).
   PubMed Web of Science ®Google Scholar
• Tumbarello M, Spanu T, Di Bidino R et al. Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy. Antimicrob. Agents Chemother. 54(10), 4085–4091 (2010).
   PubMedGoogle Scholar
• Giske CG, Monnet DL, Cars O, Carmeli Y. Clinical and economic impact of common multidrug-resistant gram-negative bacilli. Antimicrob. Agents Chemother. 52(3), 813–821 (2008).
   PubMed Web of Science ®Google Scholar
• Hirsch EB, Tam VH. Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection. J. Antimicrob. Chemother. 65(6), 1119–1125 (2011).
   Google Scholar
• Tumbarello M, Viale P, Viscoli C et al. Predictors of Mortality in Bloodstream Infections Caused by KPC-producing Klebsiella pneumoniae: Importance of Combination Therapy. Clin. Infect. Dis. (2012) ( In Press).
   Google Scholar
• Qureshi ZA, Paterson DL, Potoski BA et al. Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens. Antimicrob. Agents Chemother. 56(4), 2108–2113 (2012).
   PubMed Web of Science ®Google Scholar
• Petrosillo N, Giannella M, Lewis R, Viale P. Treatment of carbapenem-resistant Klebsiella pneumoniae: the state of the art. Expert Rev. Anti. Infect. Ther. 11(2), 159–177 (2013).
   PubMed Web of Science ®Google Scholar
• Trecarichi EM, Cauda R, Tumbarello M. Detecting risk and predicting patient mortality in patients with extended-spectrum beta-lactamase-producing Enterobacteriaceae bloodstream infections. Future Microbiol. 7(10), 1173–1189 (2012).
   PubMed Web of Science ®Google Scholar
• Tumbarello M, Sanguinetti M, Montuori E et al. Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. Antimicrob. Agents Chemother. 51(6), 1987–1994 (2007).
   PubMed Web of Science ®Google Scholar
• Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: a clinical update. Clin. Microbiol. Rev. 18(4), 657–686 (2005).
   PubMed Web of Science ®Google Scholar
• Pitout JD. Infections with extended-spectrum beta-lactamase-producing enterobacteriaceae: changing epidemiology and drug treatment choices. Drugs 70(3), 313–333 (2010).
   PubMed Web of Science ®Google Scholar
• Tumbarello M, Trecarichi EM, Bassetti M et al. Identifying patients harboring extended-spectrum-beta-lactamase-producing Enterobacteriaceae on hospital admission: derivation and validation of a scoring system. Antimicrob. Agents Chemother. 55(7), 3485–3490 (2011).
   PubMed Web of Science ®Google Scholar
• Schwaber MJ, Navon-Venezia S, Schwartz D, Carmeli Y. High levels of antimicrobial coresistance among extended-spectrum-beta-lactamase-producing Enterobacteriaceae. Antimicrob. Agents Chemother. 49(5), 2137–2139 (2005).
   PubMed Web of Science ®Google Scholar
• Schwaber MJ, Carmeli Y. Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. J. Antimicrob. Chemother. 60(5), 913–920 (2007).
   PubMed Web of Science ®Google Scholar
• Pena C, Pujol M, Ardanuy C et al. An outbreak of hospital-acquired Klebsiella pneumoniae bacteraemia, including strains producing extended-spectrum beta-lactamase. J. Hosp. Infect. 47(1), 53–59 (2001).
   PubMedGoogle Scholar
• Marra AR, Wey SB, Castelo A et al. Nosocomial bloodstream infections caused by Klebsiella pneumoniae: impact of extended-spectrum beta-lactamase (ESBL) production on clinical outcome in a hospital with high ESBL prevalence. BMC Infect. Dis. 6, 24 (2006).
   PubMed Web of Science ®Google Scholar
• Kang CI, Kim SH, Kim DM et al. Risk factors for and clinical outcomes of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae. Infect. Control Hosp. Epidemiol. 25(10), 860–867 (2004).
   PubMed Web of Science ®Google Scholar
• Tuon FF, Kruger M, Terreri M, Penteado-Filho SR, Gortz L. Klebsiella ESBL bacteremia-mortality and risk factors. Braz. J. Infect. Dis. 15(6), 594–598 (2011).
   PubMedGoogle Scholar
• Tumbarello M, Spanu T, Sanguinetti M et al. Bloodstream infections caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome. Antimicrob. Agents Chemother. 50(2), 498–504 (2006).
   PubMed Web of Science ®Google Scholar
• Mosqueda-Gomez JL, Montano-Loza A, Rolon AL et al. Molecular epidemiology and risk factors of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae A case-control study. Int. J. Infect. Dis. 12(6), 653–659 (2008).
   PubMedGoogle Scholar
• Ariffin H, Navaratnam P, Mohamed M et al. Ceftazidime-resistant Klebsiella pneumoniae bloodstream infection in children with febrile neutropenia. Int. J. Infect. Dis. 4(1), 21–25 (2000).
   PubMedGoogle Scholar
• Murphy CN, Clegg S. Klebsiella pneumoniae and type 3 fimbriae: nosocomial infection, regulation and biofilm formation. Future Microbiol. 7(8), 991–1002 (2012).
   PubMed Web of Science ®Google Scholar
• Yu VL, Hansen DS, Ko WC et al. Virulence characteristics of Klebsiella and clinical manifestations of K. pneumoniae bloodstream infections. Emerg. Infect. Dis. 13(7), 986–993 (2007).
   PubMed Web of Science ®Google Scholar
• Apisarnthanarak A, Kiratisin P, Mundy LM. Predictors of mortality from community-onset bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Infect. Control Hosp. Epidemiol. 29(7), 671–674 (2008).
   PubMedGoogle Scholar
• Anderson DJ, Engemann JJ, Harrell LJ, Carmeli Y, Reller LB, Kaye KS. Predictors of mortality in patients with bloodstream infection due to ceftazidime-resistant Klebsiella pneumoniae. Antimicrob. Agents Chemother. 50(5), 1715–1720 (2006).
   PubMed Web of Science ®Google Scholar
• Kim BN, Woo JH, Kim MN, Ryu J, Kim YS. Clinical implications of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae bacteraemia. J. Hosp. Infect. 52(2), 99–106 (2002).
   PubMedGoogle Scholar
• Paterson DL, Ko WC, Von Gottberg A, Mohapatra S, Casellas JM, Goossens H, et al. Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases. Clin. Infect. Dis. 39(1), 31–37 (2004).
   PubMed Web of Science ®Google Scholar
• Vardakas KZ, Tansarli GS, Rafailidis PI, Falagas ME. Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum beta-lactamases: a systematic review and meta-analysis. J. Antimicrob. Chemother. 67(12), 2793–2803 (2012).
   PubMed Web of Science ®Google Scholar
• Rodriguez-Bano J, Navarro MD, Retamar P, Picon E, Pascual A. beta-Lactam/beta-lactam inhibitor combinations for the treatment of bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: a post hoc analysis of prospective cohorts. Clin. Infect. Dis. 54(2), 167–174 (2012).
   PubMed Web of Science ®Google Scholar
• Gupta N, Limbago BM, Patel JB, Kallen AJ. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin. Infect. Dis. 53(1), 60–67 (2011).
   PubMed Web of Science ®Google Scholar
• Srinivasan A, Patel JB. Klebsiella pneumoniae carbapenemase-producing organisms: an ounce of prevention really is worth a pound of cure. Infect. Control Hosp. Epidemiol. 29(12), 1107–1109 (2008).
   PubMed Web of Science ®Google Scholar
• Bradford PA, Urban C, Mariano N, Projan SJ, Rahal JJ, Bush K. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the foss of an outer membrane protein. Antimicrob. Agents Chemother. 41(3), 563–569 (1997).
   PubMed Web of Science ®Google Scholar
• Orsi GB, Garcia-Fernandez A, Giordano A et al. Risk factors and clinical significance of ertapenem-resistant Klebsiella pneumoniae in hospitalised patients. J. Hosp. Infect. 78(1), 54–58 (2011).
   PubMed Web of Science ®Google Scholar
• Capone A, Giannella M, Fortini D, Giordano A, Meledandri M, Ballardini M, et al. High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality. Clin. Microbiol. Infect. 19(1), E23–30 (2013).
   PubMed Web of Science ®Google Scholar
• Sidjabat HE, Silveira FP, Potoski BA et al. Interspecies spread of Klebsiella pneumoniae carbapenemase gene in a single patient. Clin. Infect. Dis. 49(11), 1736–1738 (2009).
   PubMedGoogle Scholar
• Kwak YG, Choi SH, Choo EJ et al. Risk factors for the acquisition of carbapenem-resistant Klebsiella pneumoniae among hospitalized patients. Microb. Drug Resist. 11(2), 165–169 (2005).
   PubMedGoogle Scholar
• Schwaber MJ, Klarfeld-Lidji S, Navon-Venezia S, Schwartz D, Leavitt A, Carmeli Y. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob. Agents Chemother. 52(3), 1028–1033 (2008).
   PubMed Web of Science ®Google Scholar
• Patel G, Huprikar S, Factor SH, Jenkins SG, Calfee DP. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect. Control Hosp. Epidemiol. 29(12), 1099–1106 (2008).
   PubMed Web of Science ®Google Scholar
• Gasink LB, Edelstein PH, Lautenbach E, Synnestvedt M, Fishman NO. Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae. Infect. Control Hosp. Epidemiol. 30(12), 1180–1185 (2009).
   PubMed Web of Science ®Google Scholar
• Borer A, Saidel-Odes L, Eskira S et al. Risk factors for developing clinical infection with carbapenem-resistant Klebsiella pneumoniae in hospital patients initially only colonized with carbapenem-resistant K pneumoniae. Am. J. Infect. Control 40(5), 421–425 (2012).
   PubMed Web of Science ®Google Scholar
• Borer A, Saidel-Odes L, Riesenberg K et al. Attributable mortality rate for carbapenem-resistant Klebsiella pneumoniae bacteremia. Infect. Control Hosp. Epidemiol. 30(10), 972–976 (2009).
   PubMed Web of Science ®Google Scholar
• Kalpoe JS, Sonnenberg E, Factor SH et al. Mortality associated with carbapenem-resistant Klebsiella pneumoniae infections in liver transplant recipients. Liver Transpl. 18(4), 468–474 (2012).
   PubMed Web of Science ®Google Scholar
• Tumbarello M, Viale P, Viscoli C et al. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy. Clin. Infect. Dis. 55(7), 943–950 (2012).
   PubMed Web of Science ®Google Scholar
• Zarkotou O, Pournaras S, Tselioti P et al. Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment. Clin. Microbiol. Infect. 17(12), 1798–1803 (2011).
   PubMed Web of Science ®Google Scholar
• Nguyen M, Eschenauer GA, Bryan M, O'Neil K, Furuya EY, Della-Latta P, et al. Carbapenem-resistant Klebsiella pneumoniae bacteremia: factors correlated with clinical and microbiologic outcomes. Diagn. Microbiol. Infect. Dis. 67(2), 180–184 (2010).
   PubMedGoogle Scholar
• Neuner EA, Yeh JY, Hall GS et al. Treatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infections. Diagn. Microbiol. Infect. Dis. 69(4), 357–362 (2011).
   PubMed Web of Science ®Google Scholar
• Sbrana F, Malacarne P, Viaggi B et al. Carbapenem-sparing antibiotic regimens for infections caused by KPC-producing Klebsiella pneumoniae in Intensive Care Unit. Clin. Infect. Dis. doi: 10.1093/cid/cis969 (2012).
   PubMedGoogle Scholar
• Grgurich PE, Hudcova J, Lei Y, Sarwar A, Craven DE. Diagnosis of ventilator-associated pneumonia: controversies and working toward a gold standard. Curr. Opin. Infect. Dis. 26(2), 140–150 (2013).
   PubMedGoogle Scholar
• Daikos GL, Petrikkos P, Psichogiou M et al. Prospective observational study of the impact of VIM-1 metallo-beta-lactamase on the outcome of patients with Klebsiella pneumoniae bloodstream infections. Antimicrob. Agents Chemother. 53(5), 1868–1873 (2009).
   PubMed Web of Science ®Google Scholar
• Mouloudi E, Protonotariou E, Zagorianou A et al. Bloodstream infections caused by metallo-beta-lactamase/Klebsiella pneumoniae carbapenemase-producing K. pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes. Infect. Control Hosp. Epidemiol. 31(12), 1250–1256 (2010).
   PubMed Web of Science ®Google Scholar
• Ben-David D, Kordevani R, Keller N et al. Outcome of carbapenem-resistant Klebsiella pneumoniae bloodstream infections. Clin. Microbiol. Infect. 18(1), 54–60 (2012).
   PubMed Web of Science ®Google Scholar
• Hussein K, Raz-Pasteur A, Finkelstein R et al. Impact of carbapenem resistance on the outcome of patients' hospital-acquired bacteraemia caused by Klebsiella pneumoniae. J Hosp. Infect. 83(4), 307–313 (2013).
   PubMed Web of Science ®Google Scholar
• Bartoletti M, Lewis RE, Tumietto F et al. Prospective, Cross-Sectional Observational Study of Hospitalized Patients Colonized with Carbapenemase-Resistant Klebsiella pneumoniae (CR-KP). Presented at: 23rd European Conference on Clinical Microbiology and Infectious Diseases. Berlin, Germany, 27–30 April 2013.
   Google Scholar
• Bleumin D, Cohen MJ, Moranne O et al. Carbapenem-resistant Klebsiella pneumoniae is associated with poor outcome in hemodialysis patients. J. Infect. 65(4), 318–325 (2012).
   PubMedGoogle Scholar
• Flowers CR, Seidenfeld J, Bow EJ et al. Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline. J. Clin. Oncol. 31(6), 794–810 (2013).
   PubMed Web of Science ®Google Scholar
• Moons KG, Altman DG, Vergouwe Y, Royston P. Prognosis and prognostic research: application and impact of prognostic models in clinical practice. BMJ 338, b606 (2009).
   PubMedGoogle Scholar
• Toll DB, Janssen KJ, Vergouwe Y, Moons KG. Validation, updating and impact of clinical prediction rules: a review. J. Clin. Epidemiol. 61(11), 1085–1094 (2008).
   PubMed Web of Science ®Google Scholar
• Bosco JL, Silliman RA, Thwin SS et al. A most stubborn bias: no adjustment method fully resolves confounding by indication in observational studies. J. Clin. Epidemiol. 63(1), 64–74 (2010).
   PubMedGoogle Scholar
• Altman DG, Vergouwe Y, Royston P, Moons KG. Prognosis and prognostic research: validating a prognostic model. BMJ 338, b605 (2009).
   PubMed Web of Science ®Google Scholar
• Schaberg DR, Culver DH, Gaynes RP. Major trends in the microbial etiology of nosocomial infection. Am. J. Med. 91(3B), 72S–75S (1991).
   PubMedGoogle Scholar
• Daikos GL, Markogiannakis A, Souli M, Tzouvelekis LS. Bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae: a clinical perspective. Expert Rev. Anti. Infect. Ther. 10(12), 1393–1404 (2012).
   PubMed Web of Science ®Google Scholar
• Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect. Dis.9(4), 228–236 (2009).
   PubMed Web of Science ®Google Scholar